PhaseRx $488,958
PhenoPath Laboratories $244,479
Poniard Pharmaceuticals $244,479
Presage Biosciences $244,479
Profibrix $244,479
Proteotech $1,167,529
Qwell Pharmaceuticals $244,479
Rarecyte $244,479
Rhine Pharmaceuticals $244,479
Scolr Pharma $251,087
Silere Medical Technology $244,479
Sound Pharmaceuticals $733,435
STB $244,479
Stratos Genomics $244,479
Syntrix Biosystems $939,604
Theraclone Sciences $977,916
Tissue Regeneration Systems $244,479
Trubion Pharmaceuticals $1,222,395
Unigen $488,958
Uptake Medical $244,479
VLST $733,435
VisionGate $359,482
VPDiagnostics $244,479
XL Sci-Tech $185,409
Xori $244,479
Pages: Page 1, Page 2, Page 3, Page 4
Author: Luke Timmerman
Luke is an award-winning journalist specializing in life sciences. He has served as national biotechnology editor for Xconomy and national biotechnology reporter for Bloomberg News. Luke got started covering life sciences at The Seattle Times, where he was the lead reporter on an investigation of doctors who leaked confidential information about clinical trials to investors. The story won the Scripps Howard National Journalism Award and several other national prizes. Luke holds a bachelor’s degree in journalism from the University of Wisconsin-Madison, and during the 2005-2006 academic year, he was a Knight Science Journalism Fellow at MIT.
View all posts by Luke Timmerman
